TriLink BioTechnologies

TriLink BioTechnologies TriLink is a CDMO for synthesis of nucleic acids, NTPs and mRNA capping analogs for therapeutic, vaccine, diagnostic and biopharmaceutical breakthroughs.

02/04/2025

TriLink BioTechnologies partners with Avantor sciences to expand the availability of innovative nucleic acid products to customers in Europe

Bivalent mRNA Vaccine for Malaria—Prevention of Infection and Transmission in Mice.Explore more in the latest 'Zone In W...
11/02/2023

Bivalent mRNA Vaccine for Malaria—Prevention of Infection and Transmission in Mice.

Explore more in the latest 'Zone In With Zon' blog post:
https://bit.ly/3QpjE7I

A Universal Flu Vaccine—multivalent mRNA for all known seasonal influenza viruses. Let's explore more in the latest 'Z...
09/11/2023

A Universal Flu Vaccine—multivalent mRNA for all known seasonal influenza viruses.

Let's explore more in the latest 'Zone In With Zon' blog post:

https://bit.ly/3PffTB9

Peanut is one of the most prevalent food allergens, affecting ~2% of people worldwide, and is the leading source of food...
08/08/2023

Peanut is one of the most prevalent food allergens, affecting ~2% of people worldwide, and is the leading source of food-induced severe allergic reactions, including fatal anaphylaxis.

Let's explore mRNA vaccines for protection against peanut allergy anaphylaxis in the latest 'Zone In With Zon' blog post:

https://bit.ly/47naccG

COVID-19 demonstrated the enormous dangers posed by biological threats, severely impacting virtually every community in ...
07/05/2023

COVID-19 demonstrated the enormous dangers posed by biological threats, severely impacting virtually every community in the world. Mitigating these risks in the future is an urgent global imperative.

Let's discuss mRNA vaccines for rapid response to biological threats in the latest 'Zone In With Zon' blog post:
https://bit.ly/3pEd3Nm

Vaccines and Therapeutics for Cancer—Progress and Promise. Let's discuss more in the latest 'Zone In With Zon' blog post...
06/14/2023

Vaccines and Therapeutics for Cancer—Progress and Promise. Let's discuss more in the latest 'Zone In With Zon' blog post:

https://bit.ly/3CskOJ0mRNA

Delivery of therapeutic agents to specific cells of interest, i.e., “target cells”, is widely regarded as the “holy grai...
05/17/2023

Delivery of therapeutic agents to specific cells of interest, i.e., “target cells”, is widely regarded as the “holy grail” of drug development regardless of the drug’s molecular size or mechanism of action.

Let's discuss 4 recent examples of mRNA in the latest 'Zone In With Zon' blog post:
https://bit.ly/3o0Iv80

The vertebrate nervous system is comprised of two main parts: the central nervous system (CNS) consisting of the brain a...
04/10/2023

The vertebrate nervous system is comprised of two main parts: the central nervous system (CNS) consisting of the brain and spinal cord, and the peripheral nervous system (PNS) consisting of the neurons that connect the CNS to the rest of the body. These components collectively control all functions of the body, memory, mood, and senses, including pain.

Let's discuss mRNA therapeutics for neurological diseases and pain in the latest 'Zone In With Zon' blog post:

http://bit.ly/43jrUvP

Rare Disease Day is February 28th, 2023. In order to raise awareness, let's discuss six mRNA therapeutics in development...
02/07/2023

Rare Disease Day is February 28th, 2023. In order to raise awareness, let's discuss six mRNA therapeutics in development on the 'Zone In With Zon' blog post:

http://bit.ly/3JQPzws

Cloaking a molecule refers to the addition of a chemical modification to disguise or manipulate the molecule. Let's disc...
11/14/2022

Cloaking a molecule refers to the addition of a chemical modification to disguise or manipulate the molecule. Let's discuss mRNA to control stability and translation in cells in the latest 'Zone In With Zon' blog post:

bit.ly/3UxDONM

Hereditary Tyrosinemia type 1 (HT1) is a recessive genetic disease of amino acid metabolism. Let's explore the use of mR...
10/06/2022

Hereditary Tyrosinemia type 1 (HT1) is a recessive genetic disease of amino acid metabolism. Let's explore the use of mRNA-based therapy for HT1 in the latest 'Zone In With Zon' blog post:

https://bit.ly/3V6TlVo

Address

10770 Wateridge Cir Suite 200
San Diego, CA
92121

Opening Hours

Monday 7am - 5pm
Tuesday 7am - 5pm
Wednesday 7am - 5pm
Thursday 7am - 5pm
Friday 7am - 5pm

Telephone

+18585460004

Website

Alerts

Be the first to know and let us send you an email when TriLink BioTechnologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to TriLink BioTechnologies:

Shortcuts

Featured

Share

Category